Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil and Pentoxifylline in Diabetic Nephropathy
NCT05487755Phase 3Completed
- Sponsor
- Tanta University
- Start
- Feb 2022
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tadalafil, pentoxifylline in diabetic nephropathy (DN), sponsored by Tanta University. Started Feb 2022; status: completed.
02
Drugs
tadalafilpentoxifylline
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT05487755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05487755.